China · Delayed Price · Currency is CNY Pacific Shuanglin Bio-pharmacy Company Description
Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of blood products in China and internationally.
The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen, lyophilized intravenous immunoglobulin (pH4), hepatitis B immunoglobulin (pH4), and human prothrombin complex concentrate, as well as intravenous cytomegalovirus immunoglobulin and intravenous respiratory syncytial virus immunoglobulin.
It is also involved in blood acquisition; plasma collection; consulting; trading; investment activities; and technology promotion and application services.
The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021.
Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is headquartered in Taiyuan, China.
| Country | China |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,755 |
| CEO | Xiankui Rong |
Contact Details
Address: Sunshine City Global Financial Center Taiyuan, 030000 China | |
| Phone | 86 75 9293 1218 |
| Website | slbiop.com |
Stock Details
| Ticker Symbol | 000403 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000F14 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Xiankui Rong | General Manager |
| Lei Yan | Deputy GM and Director |
| Wenbin Si | Deputy GM and Non-Independent Director |
| Xiaoying Huang | Deputy GM and Non-Independent Director |
| Lan Ye | Deputy GM and Non-Independent Director |
| Yulin Zhao | Board Secretary |